mutations multiple genes cause deregulation nf-kappa b diffuse large b-cell lymphoma 
diffuse large b-cell lymphoma dlbcl common form lymphoma adulthood comprises multiple biologically clinically distinct subtypes including germinal centre b-cell-like gcb activated b-cell-like abc dlbcl1 gene expression profile studies shown aggressive subtype abc-dlbcl associated constitutive activation nf-kappa b transcription complex2 however except small fraction cases3 remains unclear whether nf-kappa b activation tumours represents intrinsic program tumour cell origin pathogenetic event show >% abc-dlbcl smaller fraction gcb dlbcl carry somatic mutations multiple genes including negative tnfaip3 also called a20 positive card11 traf2 traf5 map3k7 tak1 tnfrsf11a rank regulators nf-kappa b a20 gene encodes ubiquitin-modifying enzyme involved termination nf-kappa b responses commonly affected similar % patients displaying biallelic inactivation mutations and/or deletions reintroduced cell lines carrying biallelic inactivation gene a20 induced apoptosis cell growth arrest indicating tumour suppressor role less frequently missense mutations traf2 card11 produce molecules significantly enhanced ability activate nf-kappa b thus results demonstrate nf-kappa b activation dlbcl caused genetic lesions affecting multiple genes loss activation may promote lymphomagenesis leading abnormally prolonged nf-kappa b responses 
